← Evidence map

TrialHematological oncology2017

A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China.

Rong Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2017
2018
2019
2020
2021
2022
2023
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27723108